Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice

Journal of Pharmacology and Pharmacotherapeutics

Volumn 3, Issue 2, 2012, Pages 149-155

  Girish, C ^a   Pradhan, S C ^b  

^a PONDICHERRY INSTITUTE OF MEDICAL SCIENCES   (India)

^b JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hepatotoxicity; herbal drugs; lipid peroxidation; liver enzymes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ARACHIS OIL; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CATALASE; CURCUMIN; CYTOCHROME P450; ELLAGIC ACID; GLUTATHIONE; KUTKIN; MALONALDEHYDE; PHENOBARBITAL; SILYMARIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; FATTY LIVER; FEMALE; HEPATITIS; HISTOPATHOLOGY; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; SLEEP TIME; TISSUE STRUCTURE;

EID: 84869049689     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.95515     Document Type: Article

References (34)

1. Abbound G, Kaplowitz N. Drug induced liver injury. Drug Saf 2007;30:277-94
2. Medina J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs 2005;65:2445-61
3. Girish C, Pradhan SC. Drug development for liver diseases; focus on picroliv, ellagic acid and curcumin. Fundam Clin Pharmacol 2008;22:623-32
4. Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res 2006;124:491-504
5. Chander R, Kapoor NK, Dhawan BN. Picroliv, picroside-1 and kutkoside from Picrorhiza kurroa are scavengers of superoxide anions. Biochem Pharmacol 1992;44:180-3
6. Buniatian GH. Stages of activation of hepatic stellate cells: Effects of ellagic acid, an inhibitor of liver fibrosis, on their differentiation in culture. Cell Prolif 2003;36:307-19
7. Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-Terminal kinase, and apoptosis. J Immunol 1999;163:6800-9
8. Lee WJ, Ou HC, Hsu WC, Chou MM, Tseng JJ, Hsu SL, et al. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg 2010;52:1290-300
9. Anand P, Kunnumakkara AB, Harikumar KB, Ahn KS, Badmaev V, Aggarwal BB. Modification of cysteine residue in p65 subunit of nuclear factor-kappa B (NF-kappaB) by picroliv suppresses NF-kappa B-regulated gene products and potentiates apoptosis. Cancer Res 2008;68:8861-70
10. Devipriya N, Sudheer AR, Menon VP. Dose-response effect of ellagic acid on circulatory antioxidants and lipids during alcohol-induced toxicity in experimental rats. Fundam Clin Pharmacol 2007;21:621-30
11. Kaur G, Tirkey N, Bharrhan S, Chanana V, Rishi PK, Chopra K. Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents. Clin Exp Immunol 2006;145:313-21
12. Girish C, Koner BC, Jayanthi S, Rao KR, Rajesh B, Pradhan SC. Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice. Fundam Clin Pharmacol 2009;23:735-45
13. Kind PR, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-Antipyrine. J Clin Pathol 1954;7:322-6
14. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetic acid and glutamic pyruvic transaminases. Am J Clin Pathol 1957;28:56-63
15. Handa SS, Sharma A. Hepatoprotective activity of andrographolide from Andographispaniculta against carbon tetrachloride. Indian J Med Res 1990;92:276-83
16. Utley HG, Bernheim F, Hochstein P. Effect of sulfhydryl reagents on peroxidation in microsomes. Arch Biochem Biophys 1967;118:29-32
17. Smith IK, Vierheller TL, Thorne CA. Assay of glutathione reductase in crude tissue homogenates using 5,5'-dithiobis (2-nitrobenzoic acid). Anal Biochem 1988;175:408-13
18. Aebi H. Catalase in vitro. In: Fleischer S, Fleischer B, editors. Methods in enzymology. Vol. 105. San Diego: Academic Press; 1984. p. 121-6
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75
20. Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003;33:105-36
21. Rang HP, Dale MM, Ritter JM, Flower RJ. Pharmacology. 6th ed. Edinburgh: Churchill Livingstone; 2007
22. Rajesh MG, Latha MS. Preliminary evaluation of the antihepatotoxic activity of Kamilari, a polyherbal formulation. J Ethnopharmacol 2004;91:99-104
23. Pari L, Murugan P. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. Pharmacol Res 2004;49:481-6
24. Girish C, Koner BC, Jayanthi S, Rao KR, Rajesh B, Pradhan SC. Hepatoprotective activity of six polyherbal formulations in paracetamol induced liver toxicity in mice. Indian J Med Res 2009;129:105-14
25. Sugiyama T, Nagata J, Yamagishi A, Endoh K, Saito M, Yamada K, et al. Selective protection of curcumin against carbon tetrachloride-induced inactivation of hepatic cytochrome P450isozymes in rats. Life Sci 2006;78:2188-93
26. Zuber R, Modrianský M, Dvorák Z, Rohovský P, Ulrichová J, Simánek V, et al. Effect of silybin and its congeners on human liver microsomal cytochrome P450activities. Phytother Res 2002;16:632-8
27. Rastogi R, Srivastava AK, Rastogi AK. Long term effect of aflatoxin B (1) on lipid peroxidation in rat liver and kidney: Effect of picroliv and silymarin. Phytother Res 2001;15:307-10
28. Webb C, Twedt D. Oxidative stress and liver disease. Vet Clin North Am Small Anim Pract 2008;38:125-35
29. Ookhtens M, Kaplowitz N. Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine. Semin Liver Dis 1998;18:313-29
30. Campos R, Garrido A, Guerra R, Valenzuela A. Silybin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen on rat liver. Planta Med 1989;55:417-9
31. Thulstrup PW, Thormann T, Spanget-Larsen J, Bisgaard HC. Interaction between ellagic acid and calf thymus DNA studied with flow linear dichroism UV-VIS spectroscopy. Biochem Biophys Res Commun 1999;265:416-21
32. Hayeshi R, Mutingwende I, Mavengere W, Masiyanise V, Mukanganyama S. The inhibition of human glutathione S-Transferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem Toxicol 2007;45:286-95
33. Venkatesan P, Rao MN. Structural activity relationships for the inhibition of lipid peroxidation and the scavenging of free radicals by synthetic symmetrical curcumin analogues. J Pharm Pharmacol 2000;52:1123-8
34. Girish C, Koner BC, Jayanthi S, Rao KR, Rajesh B, Pradhan SC. Hepatoprotective activity of six polyherbal formulations in carbon tetrachloride induced liver toxicity in mice. Indian J Experimental Biol 2009;47:257-63